Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of OJP-001 for Recurrent or Relapsed Adult T-cell Leukemia/Lymphoma Patients With Peripheral Blood Tumor.

NCT07075328 is registered in ClinicalTrials.gov with Otsuka Medical Devices Co., Ltd. Japan as lead sponsor.

NCT NCT07075328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07075328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of OJP-001 for Recurrent or Relapsed Adult T-cell Leukemia/Lymphoma Patients With Peripheral Blood Tumor.
Lead sponsor
Otsuka Medical Devices Co., Ltd. Japan
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 1, 2024
Completion date
August 31, 2028
Enrollment
49 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adult t-cell leukemia/lymphoma (atll)